Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma

Modern Pathology

Volumn 16, Issue 2, 2003, Pages 161-165

  Barranco, Carlos ^a   Mate, José L ^a   Ariza, Aurelio ^a   Baró, Teresa ^a   Díaz, Esther ^a   Munné, Assumpta ^a   Serrano, Sergi ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Catalyzed signal amplification; Cyclin D1; Immunohistochemistry; Mantle cell lymphoma

Indexed keywords

BIOTIN; CYCLIN D1; DEXTRAN; ENVISION; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CYCLIN D1 GM; PEROXIDASE; PHENOL DERIVATIVE; STREPTAVIDIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIGEN RETRIEVAL; ARTICLE; BIOTINYLATION; CATALYZED SIGNAL AMPLIFICATION; CHROMOSOME TRANSLOCATION 11; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FOLLICULAR LYMPHOMA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPHOCYTOMA; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING;

CATALYSIS; CYCLIN D1; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL; LYMPHOMA, SMALL-CELL; PEROXIDASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037325139     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000051585.74803.09     Document Type: Article

References (20)

1. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1997;89:2067-78.
2. Bosch F, Lopez-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998;82:567-75.
3. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 1995;85:1075-82.
4. Norton AJ, Matthews J, Pappa V, Shamash J, Love S, Rohatiner AZ, et al. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 1995;6:249-56.
5. Velders GA, Kluin-Nelemans JC, De Boer CJ, Hermans J, Noordijk EM, Schuuring E, et al. Mantle-cell lymphoma: a population-based clinical study. J Clin Oncol 1996;14:1269-74.
6. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-18.
7. Weisenburger DD, Vose JM, Greiner TC, Lynch JC, Chan WC, Bierman PJ, et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol 2000;64:190-6.
8. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-6.
9. de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995;86:2715-23.
10. Zukerberg LR, Yang WI, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol 1995;103:756-60.
11. Li JY, Gaillard F, Moreau A, Harousseau JL, Laboisse C, Milpied N, et al. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol 1999;154:1449-52.
12. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992;40:1457-63.
13. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, et al. The EnVision+ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998;51:506-11.
14. Korin HW, Schwartz MR, Chirala M, Younes M. Optimized cyclin D1 immunoperoxidase staining in mantle cell lymphoma. Appl Immunohistochem Mol Morphol 2000;8:57-60.
15. Chan JKC. Reliable immunostaining of cyclin D1 is difficult, but the problems can be overcome. Histopathology 1999;34:266-8.
16. Miranda RN, Briggs RC, Kinney MC, Veno PA, Hammer RD, Cousar JB. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Mod Pathol 2000;13:1308-14.
17. Miller KD, Munson P, Isaacson. Optimizing cyclin D1 immunostaining of mantle cell lymphoma. Histopathology 1999;34:268-70.
18. Hashizume K, Hatanaka Y, Kamihara Y, Tani Y. Automated immunohistochemical staining of formalin-fixed and paraffin-embedded tissues using a catalyzed signal amplification method. Appl Immunohistochem Mol Morphol 2001;9:54-60.
19. Ott MM, Helbing A, Ott G, Bartek J, Fischer L, Durr A, et al. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 1996;179:238-42.
20. Aguilera NS, Bijwaard KE, Duncan B, Krafft AE, Chu WS, Abbondanzo SL, et al. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas. Am J Pathol 1998;153:1969-76.